Enterprise Value
2.949M
Cash
13.25M
Avg Qtr Burn
-5.376M
Short % of Float
0.00%
Insider Ownership
16.12%
Institutional Own.
8.92%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Nomacopan Details BP (Bullous Pemphigoid) | Phase 3 Data readout | |
Nomacopan Details Hematopoietic stem cell transplantation thrombotic microangiopathies | Phase 3 Data readout | |
Nomacopan Details PNH (Paroxysmal Nocturnal Hemoglobinuria) | Phase 3 Update | |
Nomacopan Details COVID-19 | Phase 2 Update | |
Nomacopan Details AKC (Atopic Keratoconjunctivitis) | Phase 1/2 Update |